Posting date: May 19, 2004

This Article Reprint (PDF) HTML Version Related Papers Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ginsburg, M. E. Search for Related Content PubMed PubMed Citation Articles by Ginsburg, M. E. Related Collections Managed Care Managed Care - Physicians Business Of Health Public Opinion Quality Of Care Health Spending Consumer Issues

Health Affairs, 10.1377/hlthaff.w4.297
Copyright © 2004 by Project HOPE

Web Exclusives

Perspective: Cost-Effectiveness: Will The Public Buy It Or Balk?

¹ Marjorie Ginsburg is executive director of Sacramento Healthcare Decisions in Rancho Cordova, California.

^*Corresponding author.

Abstract

The prospect of cost-effectiveness as a criterion for treatment for coverage decisions may be met with stiff resistance from the public. A characteristically American reverence for new technology and abhorrence at putting a price on life conflict with the premise of value-based decisions. Nevertheless, if particular checks and balances are incorporated, consumer acceptance is possible. Since health care leaders deny that cost plays a role in coverage decisions, it may be time for a more realistic and open public debate on how to incorporate cost to achieve an optimal allocation of resources.

Key Words: Business of Health, Consumer Issues, Health Spending, Managed Care, Managed Care - Physicians, Public Opinion, Quality of Care

                      What's this?